Translational Imaging in Drug Discovery and Development

Northeastern University,

Raytheon Amphitheater,

Egan Research Center,

360 Huntington Avenue

Boston, MA 02115

USA

Symposium program (8am - 5pm)

Opening Remarks:  Mark Nedelman, President and CEO, EKAM Imaging

Morning Session Chair: Jack Hoppin, PhD, Co-Founder and Managing Partner, inviCRO, LLC


Breakfast

Morning Keynote Speech: “Medical Imaging in Discovery and Translational Research”, Matt Silva, PhD, Director of Research Imaging Sciences, Amgen


“Mechanistic Modeling and Molecular Imaging in Developing Targeted Therapeutics and Imaging Biomarkers”, Kelly Orcutt, PhD, Director of Translational Imaging, inviCRO, LLC


“Pre-clinical Imaging of Targeted Drug Delivery with SPECT/CT”,  Steve Mather, PhD, Professor Emeritus, University of London


Break


Preclinical Molecular Imaging of Tumor-Targeting Antibodies and Imaging Biomarker Candidates”, Daniel Bradley, PhD, Head, Biomedical Imaging Group and Sr. Scientist II, Millennium Pharmaceuticals


Multimodal Imaging Strategies in Neuroscience Drug Development”,  Ajay Verma, MD, PhD, Vice-President of Translational Neurology and Neurodegeneration ,Biogen Idec


Exploring the impact and opportunities of preclinical imaging technology in neurodegenerative disease and cancer drug development”, Paul McCracken, PhD, Director of Imaging, Eisai Pharmaceuticals

Lunch Break

Afternoon Session Chair:  Mat Brevard, MS, National MRI Manager, BrukerBiospin


Afternoon Keynote Speech:  “Integrating Imaging Modalities for Enhanced Drug Development”,  Gerry Fox, PhD, Director, Translational Sciences, Abbott Laboratories


Imaging as a Robust, Quantitative, Medium-Throughput Assay”, Jeffery Tsao, PhD, MBA, Associate Director, Clinical Research, Translational Imaging,  Novartis Institutes for BioMedical Research


Accelerating Cancer Drug Discovery Using Imaging” ,Andrew L. Kung, M.D., Ph.D., Director, Lurie Family Imaging Center, Dana-Farber Cancer Institute


Break


Animal Model of Presymptomatic Parkinson’s Disease” , Craig Ferris,  PhD, Professor, Psychology and Pharmaceutical Sciences, Director, Center for Translational NeuroImaging, Northeastern  University


Panel Discussion Moderator:  Tony McCook, VP North American Sales, Bioscan Inc.


Participants:

Mark Meadowcroft, PhD, Bristol-Myers Squibb

Matt Silva, PhD, Amgen

Gerry Fox, PhD, Abbott

Craig Ferris, PhD, NEU

Steve Mather, PhD, Professor Emeritus, University of London